Oral anticoagulation in the hospital: Analysis of patients at risk

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 1, 2011, Pages 22-26

  Dawson, Nancy L ^b   Klipa, Dusko ^a   O'Brien, Angela K ^a   Crook, Julia E ^a   Cucchi, Melanie W ^a   Valentino, Alden K ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Anticoagulation; Hospitalization; International normalized ratio (INR); Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG INDICATION; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HOSPITALIZATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WARFARIN;

EID: 78651519462     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0473-5     Document Type: Article

References (13)

1. Hirsh J, Guyatt G, Albers GW, Harrington R, Schunemann HJ, American College of Chest Physicians (2008) Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edn. Chest 133(6 Suppl):71S-109S. Erratum in: Chest 134(4):892
2. MK Higashi DL Veenstra LM Kondo AK Wittkowsky SL Srinouanprachanh FM Farin, et al. 2002 Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy JAMA 287 13 1690 1698 1:CAS:528:DC%2BD38XisFaru7c%3D 10.1001/jama.287.13.1690 11926893
3. C van Walraven PC Austin N Oake P Wells M Mamdani AJ Forster 2007 The effect of hospitalization on oral anticoagulation control: a population-based study Thromb Res 119 6 705 714 10.1016/j.thromres.2006.05.017 16844204
4. G Palareti N Leali S Coccheri M Poggi C Manotti A D'Angelo, et al. 1996 Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT): Italian Study on Complications of Oral Anticoagulant Therapy Lancet 348 9025 423 428 1:CAS:528:DyaK28XlsValtrY%3D 10.1016/S0140-6736(96)01109-9 8709780
5. National Patient Safety Goals (2008) Oakbrook terrace (IL): The Joint Commission. c2008. http://www.jointcommission.org/PatientSafety/ NationalPatientSafetyGoals. Accessed Dec 10, 2007
6. JJ Glasheen RV Fugit AV Prochazka 2005 The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens J Gen Intern Med 20 7 653 656 10.1007/s11606-005-0113-5 16050864
7. R Quiroz M Gerhard-Herman JM Kosowsky SM DeSantis N Kucher SC McKean, et al. 2006 Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism Am J Cardiol 98 4 535 537 1:CAS:528:DC%2BD28XotFKitrs%3D 10.1016/j.amjcard.2006.02.063 16893712
8. MJ Kovacs M Rodger DR Anderson B Morrow G Kells J Kovacs, et al. 2003 Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism: a randomized, double-blind, controlled trial Ann Intern Med 138 9 714 719 1:CAS:528:DC%2BD3sXktVyhsLY%3D 12729425
9. MA Crowther JB Ginsberg C Kearon L Harrison J Johnson MP Massicotte, et al. 1999 A randomized trial comparing 5-mg and 10-mg warfarin loading doses Arch Intern Med 159 1 46 48 1:CAS:528:DyaK1MXmtVCjug%3D%3D 10.1001/archinte.159.1.46 9892329
10. L Harrison M Johnston MP Massicotte M Crowther K Moffat J Hirsh 1997 Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy Ann Intern Med 126 2 133 136 1:CAS:528:DyaK2sXpt1ensA%3D%3D 9005747
11. CD Eckhoff RJ Didomenico NL Shapiro 2004 Initiating warfarin therapy: 5 mg versus 10 mg Ann Pharmacother 38 12 2115 2121 1:CAS:528:DC%2BD2cXhtFChurrK 10.1345/aph.1E083 15522981
12. CA Bond CL Raehl 2004 Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions Pharmacotherapy 24 8 953 963 1:STN:280:DC%2BD2cvjtlCjsg%3D%3D 10.1592/phco.24.11.953.36133 15338843
13. WE Dager JM Branch JH King RH White RS Quan NA Musallam, et al. 2000 Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service Ann Pharmacother 34 5 567 572 1:STN:280:DC%2BD3cvlsVyqtQ%3D%3D 10.1345/aph.18192 10852081